- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in the management of cystic fibrosis
Authors
Keywords
-
Journal
ARCHIVES OF DISEASE IN CHILDHOOD
Volume 99, Issue 11, Pages 1033-1036
Publisher
BMJ
Online
2014-07-05
DOI
10.1136/archdischild-2013-304400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhalation Treatment with Glutathione in Patients with Cystic Fibrosis. A Randomized Clinical Trial
- (2013) Matthias Griese et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Lung Clearance Index as an Outcome Measure for Clinical Trials in Young Children with Cystic Fibrosis. A Pilot Study Using Inhaled Hypertonic Saline
- (2013) Padmaja Subbarao et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation
- (2013) Jane C. Davies et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Early intervention studies in infants and preschool children with cystic fibrosis: are we ready?
- (2013) Stephen Stick et al. EUROPEAN RESPIRATORY JOURNAL
- High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis
- (2013) Thomas Lahiri et al. PEDIATRIC PULMONOLOGY
- Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group
- (2013) D. E. Geller et al. Respiratory Care
- Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection
- (2013) J P Clancy et al. THORAX
- Inhaled Hypertonic Saline in Infants and Children Younger Than 6 Years With Cystic Fibrosis
- (2012) Margaret Rosenfeld et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long term effects of denufosol tetrasodium in patients with cystic fibrosis
- (2012) Felix Ratjen et al. Journal of Cystic Fibrosis
- Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis
- (2012) Richard B. Moss et al. Journal of Cystic Fibrosis
- Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
- (2012) Baroukh M. Assael et al. Journal of Cystic Fibrosis
- Inhaled antibiotics in cystic fibrosis: what's new?
- (2012) Simon Langton Hewer JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
- (2012) Sabrina Noel et al. Frontiers in Pharmacology
- Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis withPseudomonas aeruginosa
- (2011) David E. Geller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection
- (2011) Bruce C. Trapnell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study
- (2011) D. Bilton et al. EUROPEAN RESPIRATORY JOURNAL
- Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
- (2011) C.E. Wainwright et al. Journal of Cystic Fibrosis
- Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis
- (2011) Michael W. Konstan et al. Journal of Cystic Fibrosis
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for theF508del-CFTRmutation
- (2011) J P Clancy et al. THORAX
- Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function
- (2010) Frank J. Accurso et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis
- (2010) R. Amin et al. EUROPEAN RESPIRATORY JOURNAL
- An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis
- (2010) Christopher M. Oermann et al. PEDIATRIC PULMONOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started